• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 22, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Hyperpolarized MRI Probe Visualizes Declining Liver Enzyme Activity in Mouse Disease Models

by
November 21, 2026
in Health
Reading Time: 4 mins read
0
Hyperpolarized MRI Probe Visualizes Declining Liver Enzyme Activity in Mouse Disease Models

Hyperpolarized MRI Probe Visualizes Declining Liver Enzyme Activity in Mouse Disease Models

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers in Japan have developed an advanced magnetic resonance imaging technique that visualizes the real-time activity of an essential liver enzyme in living organisms for the first time, establishing a novel experimental pathway to detect and track metabolic fatty liver disease. The multidisciplinary investigation, conducted jointly by the National Institutes for Quantum Science and Technology alongside industrial collaborators from Nippon Sanso Corporation, introduced a hyperpolarized carbon-13 molecular probe engineered to track biochemical transformations within liver tissue. Published on November 12, 2026, in the peer-reviewed scientific journal Sensors and Diagnostics, the experimental investigation demonstrated that monitoring paraoxonase enzyme function can reveal critical physiological declines as hepatic steatosis advances. By shifting the diagnostic focus from static anatomical alterations to dynamic enzymatic performance, the collaborative research team demonstrated that specialized imaging can capture subtle functional shifts in mouse models of metabolic dysfunction-associated steatotic liver disease and its severe inflammatory manifestation, metabolic dysfunction-associated steatohepatitis.

Metabolic dysfunction-associated steatotic liver disease is a common condition in which excess fat builds up in the liver in association with metabolic disorders. The condition is estimated to affect about one in three adults. The condition can progress with few obvious warning signs. In some people, the disease progresses to metabolic dysfunction-associated steatohepatitis, liver fibrosis, cirrhosis and even liver cancer.

At the biochemical core of hepatic lipid maintenance is paraoxonase, an enzyme synthesized primarily within liver tissue that plays an indispensable physiological role in regulating lipid metabolism and mitigating damaging oxidative stress. Because of its direct mechanistic participation in mitigating oxidative damage and governing lipid turnover, the operational activity of paraoxonase has emerged as a promising functional biomarker for identifying metabolic perturbations in the liver. Nonetheless, conventional diagnostic methods that rely on standard blood samples face fundamental limitations when attempting to evaluate the true functional capacity of this enzyme. Circulating blood tests cannot accurately reflect how paraoxonase behaves within the internal liver parenchyma, where its enzymatic rate is deeply governed by the complex local biological environment and cellular surroundings.

To overcome the diagnostic blind spots of standard assays, the research group synthesized a specialized metabolic probe utilizing carbon-13-labelled mevalonolactone, formally designated as [1-¹³C]mevalonolactone, tailored specifically to target the enzymatic pathways of paraoxonase. Paraoxonase converts mevalonolactone into mevalonic acid. By measuring the magnetic resonance signals of both the unmetabolized precursor probe and the newly synthesized downstream mevalonic acid product simultaneously, the investigators established a direct comparative framework. Evaluating the ratio and comparative intensities of these two distinct molecular signatures allows researchers to quantitatively visualize and map paraoxonase catalytic activity throughout the liver parenchyma.

The researchers used a technique called hyperpolarization to temporarily boost the probe's MRI signal. Employing a specialized SpinAligner hyperpolarizer apparatus stationed at the Institute for Quantum Life Science within the National Institutes for Quantum Science and Technology, the research group achieved an extraordinary signal enhancement of approximately 230,000-fold over standard magnetic resonance conditions. The hyperpolarized state persisted long enough to reliably trace both the administered mevalonolactone probe and its enzymatic metabolic derivative in living animal subjects.

In living mice, the investigators established that a magnetic resonance scan lasting approximately twenty seconds provided sufficient acquisition time to visualize and quantify hepatic paraoxonase activity comprehensively.

The scientific team rigorously validated their imaging methodology by administering the hyperpolarized molecular probe to laboratory mice subjected to a specialized dietary regimen designed to induce metabolic dysfunction-associated steatotic liver disease and its severe progression to steatohepatitis. When contrasted against healthy control animals maintained on standard nutritional diets, the disease-model mice exhibited a pronounced and progressive reduction in hepatic paraoxonase activity that closely tracked the worsening severity of their liver condition. As steatotic accumulation and inflammatory changes intensified within the hepatic tissue, the corresponding conversion of mevalonolactone to mevalonic acid steadily diminished, producing an unambiguous decline in the recorded metabolic imaging signal. These findings show that the probe can noninvasively detect disease-associated changes in enzyme activity in the living liver with high sensitivity.

Reflecting on the experimental outcomes, Dr. Yoichi Takakusagi, Group Leader at the Institute for Quantum Life Science at the National Institutes for Quantum Science and Technology, emphasized the fundamental diagnostic philosophy driving the research. Takakusagi noted that the research team prioritized creating an imaging methodology capable of revealing what metabolic enzymes are actively doing inside the living body rather than relying solely on blood tests. He explained that their foremost engineering hurdle involved constructing a molecular probe that could generate an exceptionally robust magnetic resonance signal while remaining strictly selective in its response to paraoxonase catalysis. The new probe overcame that hurdle, allowing the researchers to visualize changes in enzyme activity associated with the progression of fatty liver disease.

The broader implications of this imaging framework extend significantly beyond the immediate characterization of metabolic fatty liver disorders. By adapting the fundamental molecular architecture of this carbon-13 probe design toward other specific metabolic enzymes, researchers anticipate that hyperpolarized magnetic resonance imaging could pioneer an entirely new category of medical diagnostics. This approach could open the way to imaging methods that visualize biochemical activity rather than anatomical changes alone. In the longer term, such techniques could contribute to earlier disease detection, assessment of disease progression, and more individualized treatment planning.

The research also represents a focused technological collaboration between academic investigators at the National Institutes for Quantum Science and Technology and industrial researchers from Nippon Sanso Corporation, whose scientists filed related patent applications while providing critical technical development.

Subject of Research: Hyperpolarized carbon-13 MRI visualization of hepatic paraoxonase activity in fatty liver disease mouse models

Article Title: New MRI approach could reveal liver disease earlier

Article References: New MRI approach could reveal liver disease earlier. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: Hyperpolarized MRI, Paraoxonase, MASLD, MASH, Mevalonolactone, Mevalonic Acid, Carbon-13, Liver Disease, Molecular Imaging, Sensors & Diagnostics, Enzyme Activity, Oxidative Stress, SpinAligner, Metabolic Dysfunction, Yoichi Takakusagi, In Vivo Imaging

News Source: Drew Townsend. (November 21, 2026). Hyperpolarized MRI Probe Visualizes Declining Liver Enzyme Activity in Mouse Disease Models. Scienmag.

Tags: carbon-13enzyme activityHyperpolarized MRIIn Vivo Imagingliver diseaseMASHMASLDmetabolic dysfunctionMevalonic AcidMevalonolactonemolecular imagingoxidative stressParaoxonaseSensors & DiagnosticsSpinAlignerYoichi Takakusagi
Share12Tweet7Share2ShareShareShare1

Related Posts

Trifluoroacetate Counterion Reduces Atherosclerosis and Plasma Lipids in Mice via PPAR-α

Trifluoroacetate Counterion Reduces Atherosclerosis and Plasma Lipids in Mice via PPAR-α

November 22, 2026
RAGE, Not TLR4, Drives Inflammatory Pain in Human Skin

RAGE, Not TLR4, Drives Inflammatory Pain in Human Skin

November 22, 2026

Direct Integration of GIS and AI in Tuberculosis Studies Remains Rare

November 22, 2026

Cortical Folding Motifs Reveal Distinct Brain Shape Variations and Asymmetry From Infancy

November 22, 2026

POPULAR NEWS

  • RAGE, Not TLR4, Drives Inflammatory Pain in Human Skin

    RAGE, Not TLR4, Drives Inflammatory Pain in Human Skin

    29 shares
    Share 12 Tweet 7
  • Phloem Girdling Drives Rhizosphere Microbial Adaptation to Belowground Carbon Limitation in Tobacco

    29 shares
    Share 12 Tweet 7
  • Direct Integration of GIS and AI in Tuberculosis Studies Remains Rare

    29 shares
    Share 12 Tweet 7
  • Cortical Folding Motifs Reveal Distinct Brain Shape Variations and Asymmetry From Infancy

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Comparative Genomics Unveils Evolutionary Lineages and Stress Genes Across Four Vigna Legumes

Trifluoroacetate Counterion Reduces Atherosclerosis and Plasma Lipids in Mice via PPAR-α

Optimized Neural Network Cuts Error in Objective Vocal Music Performance Evaluation

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.